HDFC Life Insurance Company Limited (HDFCLIFE)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- H1 FY27 individual weighted received premium grew 9%, Q2 growth 11%, market share 16.2%
- VNB grew 12% in H1, new business margin 24.7%, PAT grew 13% to ₹1,119 crore
- Annuity segment grew 3x YoY, driven by variable annuities and broad product mix
- Persistency at 83% (13-month) and 66% (61-month), some softness in ULIP renewals
- Board approved ₹500 crore subordinated debt to strengthen solvency ratio at 180%
- Regulatory consultation ongoing on distribution economics; impact uncertain
- Agency and bancassurance channels growing, new partnership with J&K Bank
- Credit protect grew 19%, critical for insurance reach; regulatory changes under discussion
- Investment variance negative due to lower equity returns and yield curve shifts
- Management confident in sustaining growth and margin expansion with continued investments
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HDFCLIFE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HDFCLIFE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on HDFC Life Insurance Company Limited
Important.
The summary above is generated automatically from HDFC Life Insurance Company Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.